Showing results (4581-4590 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|September 29, 2012
Is there a role for antioxidants in the treatment of stable angina?Dominik Schuler, Roberto Sansone, Christian Heiss, et al.Current Pharmaceutical Design|September 29, 2012
Novel strategies to target inflammatory processes in atherosclerosisToshio Imanishi, Takashi AkasakaCurrent Pharmaceutical Design|September 29, 2012
HPV infections: basis of neoplastic transformation and related molecular testsDeborah French, Laura LorenzonCurrent Pharmaceutical Design|September 29, 2012
Liquid-based cytology with HPV triage of low-grade cytological abnormalities versus conventional cytology in cervical cancer screeningMaria Fröberg, Ingrid Norman, Bo Johansson, et al.Current Pharmaceutical Design|September 29, 2012
Clinical applicability of microarray technology in the diagnosis, prognostic stratification, treatment and clinical surveillance of cervical adenocarcinomaJulie Chepovetsky, Tamara Kalir, Elisabete WeiderpassCurrent Pharmaceutical Design|September 29, 2012
The present and future of cervical cancer screening programmes in EuropePaolo Giorgi Rossi, Guglielmo RoncoCurrent Pharmaceutical Design|September 29, 2012
Mapping myeloperoxidase to identify its promiscuity properties using docking and molecular dynamics simulationsL A Ramírez-Durán, M C Rosales-Hernández, Maricarmen Hernández-Rodríguez, et al.Current Pharmaceutical Design|September 29, 2012
FDA-approved drugs selected using virtual screening bind specifically to G-quadruplex DNADáimel Castillo-González, Gisselle Pérez-Machado, Aurore Guédin, et al.Current Pharmaceutical Design|September 29, 2012
microRNA biogenesis pathway as a therapeutic target for human disease and cancerFrancesca De Santa, Ilaria Iosue, Alberto Del Rio, et al.Current Pharmaceutical Design|September 29, 2012
Immunoproteasome in cancer and neuropathologies: a new therapeutic target?Elena Bellavista, Federico Andreoli, Marco Daniele Parenti, et al.Pageof 1,008